Home109820 • KOSDAQ
add
Genematrix Inc
Previous close
₩3,750.00
Day range
₩3,355.00 - ₩4,200.00
Year range
₩2,270.00 - ₩7,180.00
Market cap
69.85B KRW
Avg Volume
2.23M
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | 2018info | Y/Y change |
|---|---|---|
Revenue | 4.73B | -8.75% |
Operating expense | 4.54B | 26.32% |
Net income | -3.11B | -111.37% |
Net profit margin | -65.61 | -131.67% |
Earnings per share | — | — |
EBITDA | -2.46B | -71.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | 2018info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.26B | 99.39% |
Total assets | 31.52B | 77.64% |
Total liabilities | 20.12B | 247.02% |
Total equity | 11.40B | — |
Shares outstanding | 16.03M | — |
Price to book | 5.55 | — |
Return on assets | -7.12% | — |
Return on capital | -7.86% | — |
Cash Flow
Net change in cash
| (KRW) | 2018info | Y/Y change |
|---|---|---|
Net income | -3.11B | -111.37% |
Cash from operations | -2.74B | -54.37% |
Cash from investing | -9.51B | -650.91% |
Cash from financing | 16.36B | 17,898.17% |
Net change in cash | 4.11B | 11,968.54% |
Free cash flow | -1.28B | 17.07% |
About
GeneMatrix Inc is a Korean company servicing molecular diagnostics. The company is listed on KOSDAQ:109820.
Its main service is to diagnose DNA mutations based on its proprietary technology of restriction fragment mass polymorphism.
GeneMatrix is affiliated with the Seoul National University Medical Center, the largest oncology center in Korea. Wikipedia
Founded
2000
Website
Employees
68
